BeOne Medicines is a global oncology company discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of novel therapeutics through its internal capabilities and collaborations. Our nearly 12,000 colleagues are driven by scientific excellence and exceptional speed to reach more patients than ever before.
Sponsored
BeOne Corporate Video
Advertisement
The Future of Integrated Care: Redefining Specialty Medication Access and Affordability
Recommended Live Webinar on Apr 1, 2026 11:00 PM - 12:00 PM CST
Advertisement
Next Up in Oncology
-
Tampa (Fla.) General Hospital has received $10 million to establish the Ian and Jean MacKechnie Immunotherapy Lab within the Tampa…
By: Elizabeth Gregerson -
From chief operating officers to division chiefs, here are 25 cancer center leadership moves Becker’s has covered in 2026:
By: Elizabeth Gregerson -
A team at Baltimore-based Johns Hopkins Kimmel Cancer Center has developed a database structure to organize and more easily study…
By: Elizabeth Gregerson
Join the Oncology leaders who start their day with Becker's
Advertisement

Leave a Reply